PAREXEL International Early Phase Clinical Unit - Baltimore — Baltimore, Maryland

PAREXEL International Early Phase Clinical Unit - Baltimore is a clinical research site located in Baltimore, Maryland, United States 21225.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PAREXEL International Early Phase Clinical Unit - Baltimore has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Hypertension, Pulmonary Arterial Hypertension.

Sponsors: Aires Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Baltimore

Browse all research sites in Maryland · View every site in Baltimore

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PAREXEL International Early Phase Clinical Unit - Baltimore?

PAREXEL International Early Phase Clinical Unit - Baltimore has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PAREXEL International Early Phase Clinical Unit - Baltimore conducted?

PAREXEL International Early Phase Clinical Unit - Baltimore has 1 clinical trials on record. Their work covers Pulmonary Hypertension, Pulmonary Arterial Hypertension.

Is PAREXEL International Early Phase Clinical Unit - Baltimore accredited by Crixeo Clinical Trials?

PAREXEL International Early Phase Clinical Unit - Baltimore has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PAREXEL International Early Phase Clinical Unit - Baltimore?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.